Damato, V., Theorell, J., Al-Diwani, A., Kienzler, A., Makuch, M., Sun, B., . . . Irani, S. (2022). Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders. National Academy of Sciences.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিDamato, V., et al. Rituximab Abrogates Aquaporin-4-specific Germinal Center Activity in Patients with Neuromyelitis Optica Spectrum Disorders. National Academy of Sciences, 2022.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিDamato, V., et al. Rituximab Abrogates Aquaporin-4-specific Germinal Center Activity in Patients with Neuromyelitis Optica Spectrum Disorders. National Academy of Sciences, 2022.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.